Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)
Clinical trial NCT07337447 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07337447
- Sponsor
- Hospices Civils de Lyon
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-04-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.